Understanding exercise capacity and blood pressure response in chronic kidney disease
Official title: Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease
Run by Emory University · NCT02947750 · Data updated 2026-11-12
This study is testing if a new exercise program and some supplements can help people with chronic kidney disease improve their ability to exercise and manage their blood pressure better.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | Emory University Academic / other |
| Locations | 3 sites (Atlanta, Georgia and 2 other locations) |
| Status | Recruiting |
| Started | October 2016 |
| Main results expected | April 30, 2027 |
| Study ends | April 30, 2027 |
| Registry record updated | May 18, 2026 |
| Trial ID | NCT02947750 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals with Stage III or IV chronic kidney disease who do not exercise regularly.
✕Probably not a fit
Patients with severe chronic kidney disease, ongoing substance abuse, or serious systemic diseases may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to investigate the reasons behind poor exercise capacity and increased blood pressure during exercise in patients with chronic kidney disease (CKD). It will explore the effects of aerobic exercise training and the administration of 6R-BH4, a drug currently approved for phenylketonuria, along with histidine and beta-alanine supplementation. Researchers will measure vascular reactivity, muscle pH, and oxygenation during exercise to understand the underlying mechanisms. The study will include both CKD patients and control participants who do not exercise regularly.
Why it matters
Potential benefit: If successful, this study could improve exercise capacity and cardiovascular health in patients with chronic kidney disease.
How similar studies have gone: Other studies have shown promising results in improving exercise capacity and vascular health in CKD patients through similar interventions, but the specific combination of treatments in this study is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria for Chronic Kidney Disease Patients: * Stage III or IV Chronic Kidney Disease, defined as reduction in estimated glomerular filtration rate (eGFR) to 15-59 cc/minute as calculated by the modified Modification of Diet in Renal Disease (MDRD) Study equation or the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation * Stable renal function, with no greater than a 30% reduction in eGFR over the prior 3 months * Does not exercise regularly (defined as exercising less than 20 minutes twice per week) * Willing and able to cooperate with the study protocol Inclusion Criteria for Control Study Participants: * Does not exercise regularly (defined as exercising less than 20 minutes twice per week) * Willing and able to cooperate with the study protocol Exclusion Criteria: * severe CKD (eGFR\<15 cc/minute) * ongoing drug or alcohol abuse * diabetic neuropathy * any serious systemic disease that might influence survival * severe anemia with hgb level \<9 g/dL * clinical evidence of congestive heart failure or ejection fraction below 35% * symptomatic heart disease determined by prior electrocardiogram, stress test, and/or history * treatment with central alpha agonists (clonidine) * uncontrolled hypertension with BP greater than 170/100 mm Hg * low blood pressure with BP less than 100/50 * pregnancy or plans to become pregnant * current treatment with monoamine oxidase (MAO) inhibitors * inability to exercise on a stationary bicycle
Where it's running
-
Emory University Hospital Midtown
Atlanta, Georgia, United States Recruiting -
Emory University Hospital
Atlanta, Georgia, United States Recruiting -
Atlanta VA Health Care System
Decatur, Georgia, United States Recruiting
Study contacts
- Principal investigator: Joe Nocera, PhD — Emory University
- Study coordinator: Jeanie Park, MD
- Email: jeanie.park@emory.edu
- Phone: 404-727-2525
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Clazakizumab for adults with high hsCRP at risk for a heart event
This study tests whether clazakizumab can lower inflammation and reduce cardiovascular risk in adults with high hsCRP and existing risk factors.
-
Living with CKD as a woman of childbearing age without dialysis or transplant
This study asks how women aged 18 and up with chronic kidney disease, not on kidney replacement therapy, experience living with the condition.
-
Balcinrenone plus dapagliflozin vs dapagliflozin alone in CKD stages 3b-4
This study tests whether balcinrenone combined with dapagliflozin works better than dapagliflozin alone in adults with CKD stage 3b–4.
-
Exercise during hemodialysis to prevent muscle loss and improve sleep
This trial will test if a 12-week supervised exercise program performed during dialysis can improve muscle mass, strength, physical performance, sleep quality, and quality of life for patients aged 40 and over on chronic hemodialysis.
-
Home-based exercise to boost fitness for people waiting for a kidney transplant
This study tests whether a 12-week, home-based exercise program plus a wearable activity tracker helps adults on the kidney transplant waiting list increase daily activity and improve physical function.
-
Transformative 2.0 for diabetic kidney disease
This project will try to see if adults with diabetic kidney disease who take SGLT2 diabetes medicines have different biological patterns in archived kidney tissue than similar people who do not take these medicines.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.